Overview

Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.

Status:
Unknown status

Trial end date:
2017-06-01

Target enrollment:

Participant gender:

Summary

A phase Ⅲ, multi-center, randomized, double-blinded, placebo and active comparator clinical trial to assess the efficacy and safety of combination therapy of Motireb 5/100 mg in functional dyspepsia patients.

Phase:

Phase 3

Details

Lead Sponsor:

IlDong Pharmaceutical Co Ltd

Treatments:

Citric Acid
Mosapride